Novavax Could Be The Next Biotech Winner In COVID-19 Vaccines
Remarkable Comeback After Years Of Disappointment
Novavax is seeing high levels of volunteers joining its US Phase III trial, despite FDA authorized COVID-19 vaccines already being available. 
